Lulifin Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis caused by Trichophyton species and Candida albicans. Lulifin Cream is applied once daily to the affected area and surrounding skin after cleansing and drying, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. The formulation is well tolerated, with minimal adverse effects reported, most commonly mild local irritation, burning sensation, or erythema at the application site. It is contraindicated in patients with known hypersensitivity to Luliconazole or any component of the cream. Use during pregnancy and lactation should be under medical supervision. Lulifin Cream offers an effective and convenient topical treatment option for managing superficial fungal infections, promoting rapid symptom resolution and preventing recurrence when used as directed.